The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome
<p dir="ltr">BackgroundAnti-Müllerian hormone (AMH) has recently emerged as a promising biomarker for the detection of polycystic ovarian morphology. In polycystic ovary syndrome (PCOS), an elevated level of AMH has been suggested to add value to the Rotterdam criteria in cases of di...
Saved in:
| Main Author: | Moaz O. Moursi (17019030) (author) |
|---|---|
| Other Authors: | Haya Salem (17019033) (author), Ayman R. Ibrahim (11753792) (author), Sandy Marzouk (17019036) (author), Sara Al-Meraghi (17019039) (author), Maha Al-Ajmi (17019042) (author), Alreem Al-Naimi (17019045) (author), Lolwa Alansari (14777833) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study
by: Alexandra E. Butler (6189536)
Published: (2020) -
Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
by: Abu Saleh Md Moin (6189512)
Published: (2021) -
Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight
by: Ilhame Diboun (3522413)
Published: (2021) -
COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
by: Abu Saleh Md Moin (6189512)
Published: (2020) -
Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
by: Abu Saleh Md Moin (6189512)
Published: (2021)